32 related articles for article (PubMed ID: 34275847)
1. Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ESβL)-producing Pseudomonas aeruginosa isolated from burn wound infections. Essential oils and their potential for utilization.
El-Shouny WA; Ali SS; Sun J; Samy SM; Ali A
Microb Pathog; 2018 Mar; 116():301-312. PubMed ID: 29407236
[TBL] [Abstract][Full Text] [Related]
2. Detection of metallo-beta-lactamase-producing genes
Monteagudo de Barros V; da Rocha BS; Rhoden J; Stein JF; Picoli SU; Rigotto C
J Water Health; 2024 Apr; 22(4):689-700. PubMed ID: 38678422
[No Abstract] [Full Text] [Related]
3. In vitro and in vivo antimicrobial activity of combined therapy of silver nanoparticles and visible blue light against Pseudomonas aeruginosa.
Nour El Din S; El-Tayeb TA; Abou-Aisha K; El-Azizi M
Int J Nanomedicine; 2016; 11():1749-58. PubMed ID: 27175075
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of multidrug-resistant Pseudomonas aeruginosa of different avian sources with pathogenicity testing and in vitro evaluation of antibacterial efficacy of silver nanoparticles against multidrug-resistant P. aeruginosa.
Marouf S; Li X; Salem HM; Ahmed ZS; Nader SM; Shaalan M; Awad FH; Zhou H; Cheang T
Poult Sci; 2023 Oct; 102(10):102995. PubMed ID: 37566970
[TBL] [Abstract][Full Text] [Related]
5. Growing Menace of Antibacterial Resistance in Clinical Isolates of Pseudomonas aeruginosa in Nepal: An Insight of Beta-Lactamase Production.
Ansari S; Dhital R; Shrestha S; Thapa S; Puri R; Chaudhary N; Khatiwada S; Gautam R
Biomed Res Int; 2016; 2016():6437208. PubMed ID: 27642599
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and high incidence of metallo-β-lactamase and AmpC-β-lactamases in nosocomial
Muddassir M; Munir S; Raza A; Basirat A; Ahmed M; Farooq U; Ahmed SS; Naqvi SZH
Iran J Basic Med Sci; 2021 Oct; 24(10):1373-1379. PubMed ID: 35096295
[TBL] [Abstract][Full Text] [Related]
7. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish.
Khairnar K; Raut MP; Chandekar RH; Sanmukh SG; Paunikar WN
BMC Vet Res; 2013 Dec; 9():264. PubMed ID: 24369750
[TBL] [Abstract][Full Text] [Related]
8. Benefits of Usage of Immobilized Silver Nanoparticles as
Korzekwa K; Kędziora A; Stańczykiewicz B; Bugla-Płoskońska G; Wojnicz D
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008720
[TBL] [Abstract][Full Text] [Related]
9. Hospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11.
Zagui GS; de Almeida OGG; Moreira NC; Silva NGA; Meschede MSC; Darini ALC; Andrade LN; Segura-Muñoz SI
Environ Res; 2024 Aug; 255():119166. PubMed ID: 38759772
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy.
Kim A; Kutschke A; Ehmann DE; Patey SA; Crandon JL; Gorseth E; Miller AA; McLaughlin RE; Blinn CM; Chen A; Nayar AS; Dangel B; Tsai AS; Rooney MT; Murphy-Benenato KE; Eakin AE; Nicolau DP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7743-52. PubMed ID: 26438502
[TBL] [Abstract][Full Text] [Related]
11. Study on the Mechanism of Levofloxacin Combined with Imipenem Against Pseudomonas aeruginosa.
Lu Q; Yang Q
Appl Biochem Biotechnol; 2024 Feb; 196(2):690-700. PubMed ID: 37178250
[TBL] [Abstract][Full Text] [Related]
12. Chiral Nanoclusters as Alternative Therapeutic Strategies to Confront the Health Threat from Antibiotic-Resistant Pathogens.
Wang Z; Tian Y; Hao J; Liu Y; Tang J; Xu Z; Liu Y; Tang B; Huang X; Zhu N; Li Z; Hu L; Li L; Wang Y; Jiang G
ACS Nano; 2024 Mar; 18(9):7253-7266. PubMed ID: 38380803
[No Abstract] [Full Text] [Related]
13. Determining the cytotoxicity of the Minimum Inhibitory Concentration (MIC) of silver and zinc oxide nanoparticles in ESBL and carbapenemase producing Proteus mirabilis isolated from clinical samples in Shiraz, Southwest Iran.
Kakian F; Mirzaei E; Moattari A; Takallu S; Bazargani A
BMC Res Notes; 2024 Jan; 17(1):40. PubMed ID: 38287416
[TBL] [Abstract][Full Text] [Related]
14. Antibiogram Profile and Detection of Resistance Genes in
Okafor JU; Nwodo UU
Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887218
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Silver Nanoparticles on Pyocyanin Production of
Najafi M; Nakhaei Moghaddam M; Yousefi E
Avicenna J Med Biotechnol; 2021; 13(2):98-103. PubMed ID: 34012526
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the first reported outbreak of New Delhi metallo-β-lactamase-1-producing
Sopirala MM; Hartless K; Reid S; Christie-Smith A; Fiveash J; Badejogbin A; Psenicka AO
Antimicrob Steward Healthc Epidemiol; 2024; 3(1):e251. PubMed ID: 38178880
[TBL] [Abstract][Full Text] [Related]
17. Elaboration of Nanostructured Levan-Based Colloid System as a Biological Alternative with Antimicrobial Activity for Applications in the Management of Pathogenic Microorganisms.
Radenkovs V; Valdovska A; Galina D; Cairns S; Jakovlevs D; Gaidukovs S; Cinkmanis I; Juhnevica-Radenkova K
Nanomaterials (Basel); 2023 Nov; 13(22):. PubMed ID: 37999323
[TBL] [Abstract][Full Text] [Related]
18. Estimation, Evaluation and Characterization of Carbapenem Resistance Burden from a Tertiary Care Hospital, Pakistan.
Gondal AJ; Choudhry N; Bukhari H; Rizvi Z; Jahan S; Yasmin N
Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978392
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (blaNDM, blaVIM, blaOXA) producing clinically isolated Pseudomonas aeruginosa.
Qureshi R; Qamar MU; Shafique M; Muzammil S; Rasool MH; Ahmad I; Ejaz H
Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):237-243. PubMed ID: 34275847
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
